162 related articles for article (PubMed ID: 30558158)
1. Enhancement of Berberine Hypoglycemic Activity by Oligomeric Proanthocyanidins.
Zhang H; Wang X; Wang T; Chen K; Wang H; Jia Q; Li Y
Molecules; 2018 Dec; 23(12):. PubMed ID: 30558158
[TBL] [Abstract][Full Text] [Related]
2. Tetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function.
Shan YQ; Zhu YP; Pang J; Wang YX; Song DQ; Kong WJ; Jiang JD
Biol Pharm Bull; 2013; 36(10):1562-9. PubMed ID: 23924821
[TBL] [Abstract][Full Text] [Related]
3. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux.
Shan YQ; Ren G; Wang YX; Pang J; Zhao ZY; Yao J; You XF; Si SY; Song DQ; Kong WJ; Jiang JD
Metabolism; 2013 Mar; 62(3):446-56. PubMed ID: 23079743
[TBL] [Abstract][Full Text] [Related]
4. Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect.
Yin J; Hou Y; Yin Y; Song X
Int J Nanomedicine; 2017; 12():8671-8680. PubMed ID: 29263662
[TBL] [Abstract][Full Text] [Related]
5. Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer.
Toden S; Ravindranathan P; Gu J; Cardenas J; Yuchang M; Goel A
Sci Rep; 2018 Feb; 8(1):3335. PubMed ID: 29463813
[TBL] [Abstract][Full Text] [Related]
6. Different structures of berberine and five other protoberberine alkaloids that affect P-glycoprotein-mediated efflux capacity.
Zhang YT; Yu YQ; Yan XX; Wang WJ; Tian XT; Wang L; Zhu WL; Gong LK; Pan GY
Acta Pharmacol Sin; 2019 Jan; 40(1):133-142. PubMed ID: 30442987
[TBL] [Abstract][Full Text] [Related]
7. Oligomeric proanthocyanidins (OPCs) from grape seed extract suppress the activity of ABC transporters in overcoming chemoresistance in colorectal cancer cells.
Ravindranathan P; Pasham D; Goel A
Carcinogenesis; 2019 May; 40(3):412-421. PubMed ID: 30596962
[TBL] [Abstract][Full Text] [Related]
8. Nanoemulsion improves hypoglycemic efficacy of berberine by overcoming its gastrointestinal challenge.
Xu HY; Liu CS; Huang CL; Chen L; Zheng YR; Huang SH; Long XY
Colloids Surf B Biointerfaces; 2019 Sep; 181():927-934. PubMed ID: 31382342
[TBL] [Abstract][Full Text] [Related]
9. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
[TBL] [Abstract][Full Text] [Related]
10. The involvement of P-glycoprotein in berberine absorption.
Pan GY; Wang GJ; Liu XD; Fawcett JP; Xie YY
Pharmacol Toxicol; 2002 Oct; 91(4):193-7. PubMed ID: 12530470
[TBL] [Abstract][Full Text] [Related]
11. In vitro intestinal transport of oligomeric procyanidins (DP 2 to 4) across monolayers of Caco-2 cells.
Zumdick S; Deters A; Hensel A
Fitoterapia; 2012 Oct; 83(7):1210-7. PubMed ID: 22776719
[TBL] [Abstract][Full Text] [Related]
12. Mixed Micelles with Galactose Ligands for the Oral Delivery of Berberine to Enhance Its Bioavailability and Hypoglycemic Effects.
Kang H; Yao Y; Zhang X
J Biomed Nanotechnol; 2020 Dec; 16(12):1755-1764. PubMed ID: 33485402
[TBL] [Abstract][Full Text] [Related]
13. Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats.
Jia Y; Xu B; Xu J
Pharm Biol; 2017 Dec; 55(1):510-515. PubMed ID: 27937081
[TBL] [Abstract][Full Text] [Related]
14. A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer.
Ravindranathan P; Pasham D; Balaji U; Cardenas J; Gu J; Toden S; Goel A
Sci Rep; 2018 Sep; 8(1):13869. PubMed ID: 30218018
[TBL] [Abstract][Full Text] [Related]
15. Oligomeric proanthocyanidins attenuate airway inflammation in asthma by inhibiting dendritic cells maturation.
Li Y; Yu Q; Zhao W; Zhang J; Liu W; Huang M; Zeng X
Mol Immunol; 2017 Nov; 91():209-217. PubMed ID: 28963930
[TBL] [Abstract][Full Text] [Related]
16. Improvement of intestinal transport, absorption and anti-diabetic efficacy of berberine by using Gelucire44/14: In vitro, in situ and in vivo studies.
Sun J; Bao H; Peng Y; Zhang H; Sun Y; Qi J; Zhang H; Gao Y
Int J Pharm; 2018 Jun; 544(1):46-54. PubMed ID: 29654898
[TBL] [Abstract][Full Text] [Related]
17. Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450.
Zhu S; Huang R; Hong M; Jiang Y; Hu Z; Liu C; Pei Y
Eur J Pharm Sci; 2009 Jul; 37(5):573-80. PubMed ID: 19442720
[TBL] [Abstract][Full Text] [Related]
18. 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models.
Cheng Z; Chen AF; Wu F; Sheng L; Zhang HK; Gu M; Li YY; Zhang LN; Hu LH; Li JY; Li J
Bioorg Med Chem; 2010 Aug; 18(16):5915-24. PubMed ID: 20663675
[TBL] [Abstract][Full Text] [Related]
19. Microvilli Morphology Can Affect Efflux Active P-Glycoprotein in Confluent MDCKII -hMDR1-NKI and Caco-2 Cell Monolayers.
Meng Z; Le Marchand S; Agnani D; Szapacs M; Ellens H; Bentz J
Drug Metab Dispos; 2017 Feb; 45(2):145-151. PubMed ID: 27856525
[TBL] [Abstract][Full Text] [Related]
20. Oligomeric proanthocyanidins from grape seeds effectively inhibit ultraviolet-induced melanogenesis of human melanocytes in vitro.
Zi SX; Ma HJ; Li Y; Liu W; Yang QQ; Zhao G; Lian S
Int J Mol Med; 2009 Feb; 23(2):197-204. PubMed ID: 19148543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
